why choose us

First received: June 13, 2023

Clinical Trial: Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Sickle Cell Disease

Study Type: INTERVENTIONAL


Official Title: A Phase I Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease

Brief Summary: Background:Sickle cell disease (SCD) is a genetic disease that causes the body to produce abnormal ( sickled ) red blood cells.SCD can cause anemia and life-threatening complications in the lungs, heart, kidney, and nerves.People with SCD are also at increased risk of forming blood clots in the veins and lungs, but the standard treatments for these clots can cause increased bleeding in people with SCD.Better treatments are needed.Objective:To test a drug (fostamatinib) in people with SCD.Eligibility:People aged 18…

Read more